Suppr超能文献

丝氨酸蛋白酶抑制剂特异性的演变:抗凝血酶反应位点环序列中的协同相互作用特异性地限制了活化蛋白C的抑制作用。

Evolution of serpin specificity: cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C.

作者信息

Hopkins P C, Pike R N, Stone S R

机构信息

Gladstone Institute of Cardiovascular Disease and Cardiovascular Research Institute, University of California, San Francisco, CA 94141-9100, USA.

出版信息

J Mol Evol. 2000 Nov;51(5):507-15. doi: 10.1007/s002390010114.

Abstract

Protease cascades and their inhibitors are a common feature of many biological regulatory systems, and the various components of such cascades have been subjected to a long and concerted evolution. We present here evidence that in the coagulation cascade, the sequence of the protease-binding reactive-site loop of antithrombin has evolved such that the majority of its residues has been acquired not for the efficient inhibition of its target proteases, thrombin and factor Xa, but to avoid the inhibition of activated protein C (APC). We substituted residues of the reactive-site loop of antithrombin into alpha(1)-antitrypsin and tested the chimeras against thrombin, factor Xa, and APC. With respect to factor Xa and thrombin, the difference in association rate between the fastest and the slowest inhibitors was 5.5- and 88-fold, respectively. However, with respect to APC the difference was 12,500-fold. While most of the variation in the inhibition rates of thrombin could be accounted for by P2 Gly-to-Pro substitutions, for APC almost every residue had an effect on inhibition. In 22 of 25 direct comparisons of antitrypsin residues with antithrombin residues, either singly or in blocs, the antithrombin residues caused a decrease in the rate of inhibition of APC. The antithrombin residue Asn393, at position P'3, emerged as particularly important for avoiding the inhibition of APC, however, its 190-fold effect was seen only when in conjunction with antithrombin P7 to P'2 residues. Cooperative effects among residues of the reactive-site loop thus emerged as critical for restricting the activity of this sequence against APC.

摘要

蛋白酶级联反应及其抑制剂是许多生物调节系统的共同特征,并且此类级联反应的各个组分经历了漫长而协同的进化过程。我们在此展示的证据表明,在凝血级联反应中,抗凝血酶蛋白酶结合反应位点环的序列已经进化,使得其大多数残基并非为了有效抑制其靶蛋白酶凝血酶和因子Xa而获得,而是为了避免对活化蛋白C(APC)的抑制。我们将抗凝血酶反应位点环的残基替换到α1抗胰蛋白酶中,并针对凝血酶、因子Xa和APC对嵌合体进行了测试。就因子Xa和凝血酶而言,最快和最慢抑制剂之间的结合速率差异分别为5.5倍和88倍。然而,就APC而言,差异为12500倍。虽然凝血酶抑制率的大部分变化可由P2位甘氨酸到脯氨酸的取代来解释,但对于APC而言,几乎每个残基都对抑制有影响。在25次将抗胰蛋白酶残基与抗凝血酶残基单独或成组进行的直接比较中,有22次抗凝血酶残基导致APC抑制率降低。抗凝血酶在P'3位置的残基Asn393对于避免APC的抑制显得尤为重要,然而,只有当它与抗凝血酶P7至P'2残基结合时,才会出现190倍的效果。因此,反应位点环残基之间的协同效应对于限制该序列对APC的活性至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验